Theralase Technologies Inc.

TSXV:TLT Stock Report

Market Cap: CA$61.9m

Theralase Technologies Future Growth

Future criteria checks 6/6

Theralase Technologies is forecast to grow earnings and revenue by 75.4% and 71.4% per annum respectively. EPS is expected to grow by 72% per annum. Return on equity is forecast to be 48.5% in 3 years.

Key information

75.4%

Earnings growth rate

72.0%

EPS growth rate

Medical Equipment earnings growth17.0%
Revenue growth rate71.4%
Future return on equity48.5%
Analyst coverage

Low

Last updated28 Nov 2024

Recent future growth updates

Recent updates

Is Theralase Technologies (CVE:TLT) In A Good Position To Deliver On Growth Plans?

Jul 29
Is Theralase Technologies (CVE:TLT) In A Good Position To Deliver On Growth Plans?

We're Not Very Worried About Theralase Technologies' (CVE:TLT) Cash Burn Rate

Apr 08
We're Not Very Worried About Theralase Technologies' (CVE:TLT) Cash Burn Rate

Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation

Dec 24
Here's Why We're Not Too Worried About Theralase Technologies' (CVE:TLT) Cash Burn Situation

Earnings and Revenue Growth Forecasts

TSXV:TLT - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026346N/A191
12/31/20252-5N/A-51
12/31/20241-4N/A-41
9/30/20241-4-4-4N/A
6/30/20241-4-3-3N/A
3/31/20241-4-4-4N/A
12/31/20231-5-4-4N/A
9/30/20231-4-4-4N/A
6/30/20231-5-5-5N/A
3/31/20231-5-5-5N/A
12/31/20221-5-5-5N/A
9/30/20221-6-5-5N/A
6/30/20221-5-5-5N/A
3/31/20221-5-4-4N/A
12/31/20211-4-4-4N/A
9/30/20211-4-4-4N/A
6/30/20211-4-4-3N/A
3/31/20211-5-4-4N/A
12/31/20201-6-5-4N/A
9/30/20201-8-6-6N/A
6/30/20201-8-7-7N/A
3/31/20201-8-7-7N/A
12/31/20191-7-7-7N/A
9/30/20191-5-5-5N/A
6/30/20191-4-3-3N/A
3/31/20191-3-2-2N/A
12/31/20182-3-1-1N/A
9/30/20182-4-1-1N/A
6/30/20182-5N/A-2N/A
3/31/20182-6N/A-3N/A
12/31/20172-6N/A-4N/A
9/30/20172-6N/A-5N/A
6/30/20172-6N/A-6N/A
3/31/20172-5N/A-6N/A
12/31/20162-5N/A-5N/A
9/30/20162-5N/A-5N/A
6/30/20162-5N/A-5N/A
3/31/20162-5N/A-5N/A
12/31/20152-5N/A-5N/A
9/30/20151-5N/A-4N/A
6/30/20151-4N/A-4N/A
3/31/20151-3N/A-3N/A
12/31/20141-3N/A-4N/A
9/30/20141-2N/A-4N/A
6/30/20141-1N/A-3N/A
3/31/20141-1N/A-2N/A
12/31/20131-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TLT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: TLT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: TLT is expected to become profitable in the next 3 years.

Revenue vs Market: TLT's revenue (71.4% per year) is forecast to grow faster than the Canadian market (7.3% per year).

High Growth Revenue: TLT's revenue (71.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TLT's Return on Equity is forecast to be very high in 3 years time (48.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:55
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Theralase Technologies Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas LoeEchelon Wealth Partners Inc.
Andre UddinResearch Capital Corporation